Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07187245

Feasibility of the Reality PAWS Program for Children in Isolation

Reality PAWS: Examining the Feasibility of a Mixed Reality Dog Visitation Program for Hospitalized Children in Isolation

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
50 (estimated)
Sponsor
Children's Hospital Colorado · Academic / Other
Sex
All
Age
8 Years – 21 Years
Healthy volunteers
Not accepted

Summary

The goal of this clinical trial is to learn if a mixed reality program, Reality PAWS, delivered on a Meta Quest 3 VR headset, is a feasible intervention for pediatric patients in isolation. It will also evaluate the safety of the program and its effect on pain, anxiety, and loneliness. The main questions the study aims to answer are: What is the feasibility of utilizing Reality PAWS MR as a substitute for in-person dog therapy for children under isolation precautions? Are patients compliant with using Reality PAWS MR? What are the interventional outcomes of Reality PAWS MR? Participants will: Wear a Meta Quest 3 VR headset with the Reality PAWS program. Interact with the program. Answer surveys regarding demographics, anxiety, pain, loneliness, sickness, perceived exertion, and immersion in the program.

Conditions

Interventions

TypeNameDescription
DEVICEReality PAWS Program via Meta Quest 3 VRReality PAWS is a mixed reality (MR) game that allows patients to interact with a virtual dog. It was developed at Children's Hospital Colorado to serve patients under isolation precautions who are unable to be visited by a facility dog in person. Patients can interact with the game through features such as walking the dog, providing commands, outfitting the dog, giving treats, playing fetch, petting the dog, and playing with others.

Timeline

Start date
2026-01-29
Primary completion
2026-07-01
Completion
2026-07-01
First posted
2025-09-22
Last updated
2026-04-08

Locations

2 sites across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT07187245. Inclusion in this directory is not an endorsement.